The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study
β Scribed by E. J. Macaskill; J. M. S. Bartlett; V. S. Sabine; D. Faratian; L. Renshaw; S. White; F. M. Campbell; O. Young; L. Williams; J. S. Thomas; M. D. Barber; J. M. Dixon
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 316 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Dysregulation of phosphatase and tensin homolog (PTEN) and the gene that encodes the p110Ξ± catalytic subunit of phosphatidylinositolβ3βkinase (PI3K), PIK3CA, are the most common mutations in endometrial carcinoma (EC). Loss of PTEN or activation of PIK3CA results in cons
A randomized population-based study has been carried out since 1985 in Leningrad in order to evaluate the efficacy of breast self-examination (BSE) in early breast cancer detection. The population under study covers 120,310 women aged 40-64 years with no history of breast cancer. About half of these
The hypothesis that obesity plays a role in the prognosis of breast cancer is examined in this preliminary analysis of a follow-up study of 472 early-stage breast cancer patients. The 75th percentile values of weight (= 73 kg) and body mass index (BMI = 28) in the total patient population were taken